D Choquet, H Korn. J Gen Physiol 1992
Times Cited: 119
Times Cited: 119
Times Cited
Times Co-cited
Similarity
Gating-dependent mechanism of 4-aminopyridine block in two related potassium channels.
G E Kirsch, J A Drewe. J Gen Physiol 1993
G E Kirsch, J A Drewe. J Gen Physiol 1993
32
Site of action and active form of aminopyridines in squid axon membranes.
G E Kirsch, T Narahashi. J Pharmacol Exp Ther 1983
G E Kirsch, T Narahashi. J Pharmacol Exp Ther 1983
41
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
O P Hamill, A Marty, E Neher, B Sakmann, F J Sigworth. Pflugers Arch 1981
O P Hamill, A Marty, E Neher, B Sakmann, F J Sigworth. Pflugers Arch 1981
23
A characterization of the activating structural rearrangements in voltage-dependent Shaker K+ channels.
K McCormack, W J Joiner, S H Heinemann. Neuron 1994
K McCormack, W J Joiner, S H Heinemann. Neuron 1994
21
Dynamics of aminopyridine block of potassium channels in squid axon membrane.
J Z Yeh, G S Oxford, C H Wu, T Narahashi. J Gen Physiol 1976
J Z Yeh, G S Oxford, C H Wu, T Narahashi. J Gen Physiol 1976
21
Segmental exchanges define 4-aminopyridine binding and the inner mouth of K+ pores.
G E Kirsch, C C Shieh, J A Drewe, D F Vener, A M Brown. Neuron 1993
G E Kirsch, C C Shieh, J A Drewe, D F Vener, A M Brown. Neuron 1993
20
The calcium-independent transient outward potassium current in isolated ferret right ventricular myocytes. II. Closed state reverse use-dependent block by 4-aminopyridine.
D L Campbell, Y Qu, R L Rasmusson, H C Strauss. J Gen Physiol 1993
D L Campbell, Y Qu, R L Rasmusson, H C Strauss. J Gen Physiol 1993
22
On the active form of 4-aminopyridine: block of K+ currents in rabbit Schwann cells.
J R Howe, J M Ritchie. J Physiol 1991
J R Howe, J M Ritchie. J Physiol 1991
35
Aminopyridines block an inactivating potassium current having slow recovery kinetics.
P K Wagoner, G S Oxford. Biophys J 1990
P K Wagoner, G S Oxford. Biophys J 1990
45
4-Aminopyridine causes a voltage-dependent block of the transient outward K+ current in rat melanotrophs.
S J Kehl. J Physiol 1990
S J Kehl. J Physiol 1990
52
On the mechanism of 4-aminopyridine action on the cloned mouse brain potassium channel mKv1.1.
G J Stephens, J C Garratt, B Robertson, D G Owen. J Physiol 1994
G J Stephens, J C Garratt, B Robertson, D G Owen. J Physiol 1994
28
Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons.
C M Armstrong. J Gen Physiol 1971
C M Armstrong. J Gen Physiol 1971
16
Modulation of aminopyridine block of potassium currents in squid axon.
G E Kirsch, J Z Yeh, G S Oxford. Biophys J 1986
G E Kirsch, J Z Yeh, G S Oxford. Biophys J 1986
34
Characterization of 4-aminopyridine block of the transient outward K+ current in adult rat ventricular myocytes.
N A Castle, M T Slawsky. J Pharmacol Exp Ther 1993
N A Castle, M T Slawsky. J Pharmacol Exp Ther 1993
21
Modulation of 4-AP block of a mammalian A-type K channel clone by channel gating and membrane voltage.
J A Yao, G N Tseng. Biophys J 1994
J A Yao, G N Tseng. Biophys J 1994
35
Molecular basis of functional diversity of voltage-gated potassium channels in mammalian brain.
W Stühmer, J P Ruppersberg, K H Schröter, B Sakmann, M Stocker, K P Giese, A Perschke, A Baumann, O Pongs. EMBO J 1989
W Stühmer, J P Ruppersberg, K H Schröter, B Sakmann, M Stocker, K P Giese, A Perschke, A Baumann, O Pongs. EMBO J 1989
13
Block by 4-aminopyridine of a Kv1.2 delayed rectifier K+ current expressed in Xenopus oocytes.
S N Russell, N G Publicover, P J Hart, A Carl, J R Hume, K M Sanders, B Horowitz. J Physiol 1994
S N Russell, N G Publicover, P J Hart, A Carl, J R Hume, K M Sanders, B Horowitz. J Physiol 1994
26
Use-dependent effects of 4-aminopyridine on transient outward current in dog ventricular muscle.
J Simurda, M Simurdová, G Christé. Pflugers Arch 1989
J Simurda, M Simurdová, G Christé. Pflugers Arch 1989
32
Biophysical and molecular mechanisms of Shaker potassium channel inactivation.
T Hoshi, W N Zagotta, R W Aldrich. Science 1990
T Hoshi, W N Zagotta, R W Aldrich. Science 1990
12
Two types of inactivation in Shaker K+ channels: effects of alterations in the carboxy-terminal region.
T Hoshi, W N Zagotta, R W Aldrich. Neuron 1991
T Hoshi, W N Zagotta, R W Aldrich. Neuron 1991
12
Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5.
R Bouchard, D Fedida. J Pharmacol Exp Ther 1995
R Bouchard, D Fedida. J Pharmacol Exp Ther 1995
18
Proceedings: The actions of 4-aminopyridine on the delayed potassium current in skeletal muscle fibres.
J I Gillespie, O F Hutter. J Physiol 1975
J I Gillespie, O F Hutter. J Physiol 1975
11
Tetraethylammonium blockade distinguishes two inactivation mechanisms in voltage-activated K+ channels.
K L Choi, R W Aldrich, G Yellen. Proc Natl Acad Sci U S A 1991
K L Choi, R W Aldrich, G Yellen. Proc Natl Acad Sci U S A 1991
11
Inactivation properties of voltage-gated K+ channels altered by presence of beta-subunit.
J Rettig, S H Heinemann, F Wunder, C Lorra, D N Parcej, J O Dolly, O Pongs. Nature 1994
J Rettig, S H Heinemann, F Wunder, C Lorra, D N Parcej, J O Dolly, O Pongs. Nature 1994
10
Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels.
J López-Barneo, T Hoshi, S H Heinemann, R W Aldrich. Recept Channels 1993
J López-Barneo, T Hoshi, S H Heinemann, R W Aldrich. Recept Channels 1993
10
TEA prevents inactivation while blocking open K+ channels in human T lymphocytes.
S Grissmer, M Cahalan. Biophys J 1989
S Grissmer, M Cahalan. Biophys J 1989
10
Mutational analysis of ion conduction and drug binding sites in the inner mouth of voltage-gated K+ channels.
C C Shieh, G E Kirsch. Biophys J 1994
C C Shieh, G E Kirsch. Biophys J 1994
15
3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome.
K M McEvoy, A J Windebank, J R Daube, P A Low. N Engl J Med 1989
K M McEvoy, A J Windebank, J R Daube, P A Low. N Engl J Med 1989
9
Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis.
S R Schwid, M D Petrie, M P McDermott, D S Tierney, D H Mason, A D Goodman. Neurology 1997
S R Schwid, M D Petrie, M P McDermott, D S Tierney, D H Mason, A D Goodman. Neurology 1997
9
Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
S Grissmer, A N Nguyen, J Aiyar, D C Hanson, R J Mather, G A Gutman, M J Karmilowicz, D D Auperin, K G Chandy. Mol Pharmacol 1994
S Grissmer, A N Nguyen, J Aiyar, D C Hanson, R J Mather, G A Gutman, M J Karmilowicz, D D Auperin, K G Chandy. Mol Pharmacol 1994
9
A model for 4-aminopyridine action on K channels: similarities to tetraethylammonium ion action.
C M Armstrong, A Loboda. Biophys J 2001
C M Armstrong, A Loboda. Biophys J 2001
15
Inactivation of the potassium conductance and related phenomena caused by quaternary ammonium ion injection in squid axons.
C M Armstrong. J Gen Physiol 1969
C M Armstrong. J Gen Physiol 1969
9
The internal quaternary ammonium receptor site of Shaker potassium channels.
K L Choi, C Mossman, J Aubé, G Yellen. Neuron 1993
K L Choi, C Mossman, J Aubé, G Yellen. Neuron 1993
8
The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres.
H Bostock, T A Sears, R M Sherratt. J Physiol 1981
H Bostock, T A Sears, R M Sherratt. J Physiol 1981
8
4-Aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels.
N A Castle, S R Fadous, D E Logothetis, G K Wang. Mol Pharmacol 1994
N A Castle, S R Fadous, D E Logothetis, G K Wang. Mol Pharmacol 1994
27
Potency of 3,4-diaminopyridine and 4-aminopyridine on mammalian neuromuscular transmission and the effect of pH changes.
J Molgó, H Lundh, S Thesleff. Eur J Pharmacol 1980
J Molgó, H Lundh, S Thesleff. Eur J Pharmacol 1980
8
Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current.
D Fedida, B Wible, Z Wang, B Fermini, F Faust, S Nattel, A M Brown. Circ Res 1993
D Fedida, B Wible, Z Wang, B Fermini, F Faust, S Nattel, A M Brown. Circ Res 1993
8
Molecular diversity of K+ channels.
W A Coetzee, Y Amarillo, J Chiu, A Chow, D Lau, T McCormack, H Moreno, M S Nadal, A Ozaita, D Pountney,[...]. Ann N Y Acad Sci 1999
W A Coetzee, Y Amarillo, J Chiu, A Chow, D Lau, T McCormack, H Moreno, M S Nadal, A Ozaita, D Pountney,[...]. Ann N Y Acad Sci 1999
8
Bi-stable block by 4-aminopyridine of a transient K+ channel (Kv1.4) cloned from ferret ventricle and expressed in Xenopus oocytes.
R L Rasmusson, Y Zhang, D L Campbell, M B Comer, R C Castellino, S Liu, H C Strauss. J Physiol 1995
R L Rasmusson, Y Zhang, D L Campbell, M B Comer, R C Castellino, S Liu, H C Strauss. J Physiol 1995
26
The S4-S5 loop contributes to the ion-selective pore of potassium channels.
P A Slesinger, Y N Jan, L Y Jan. Neuron 1993
P A Slesinger, Y N Jan, L Y Jan. Neuron 1993
7
Aminopyridine block of Kv1.1 potassium channels expressed in mammalian cells and Xenopus oocytes.
N A Castle, S Fadous, D E Logothetis, G K Wang. Mol Pharmacol 1994
N A Castle, S Fadous, D E Logothetis, G K Wang. Mol Pharmacol 1994
30
Effects of 4-aminopyridine on potassium currents in a molluscan neuron.
A Hermann, A L Gorman. J Gen Physiol 1981
A Hermann, A L Gorman. J Gen Physiol 1981
7
The structure of the potassium channel: molecular basis of K+ conduction and selectivity.
D A Doyle, J Morais Cabral, R A Pfuetzner, A Kuo, J M Gulbis, S L Cohen, B T Chait, R MacKinnon. Science 1998
D A Doyle, J Morais Cabral, R A Pfuetzner, A Kuo, J M Gulbis, S L Cohen, B T Chait, R MacKinnon. Science 1998
7
Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels.
M Garcia-Calvo, R J Leonard, J Novick, S P Stevens, W Schmalhofer, G J Kaczorowski, M L Garcia. J Biol Chem 1993
M Garcia-Calvo, R J Leonard, J Novick, S P Stevens, W Schmalhofer, G J Kaczorowski, M L Garcia. J Biol Chem 1993
6
3,4-diaminopyridine. A potent new potassium channel blocker.
G E Kirsch, T Narahashi. Biophys J 1978
G E Kirsch, T Narahashi. Biophys J 1978
6
4-Aminopyridine in the treatment of Alzheimer's disease.
M Davidson, Z Zemishlany, R C Mohs, T B Horvath, P Powchik, J P Blass, K L Davis. Biol Psychiatry 1988
M Davidson, Z Zemishlany, R C Mohs, T B Horvath, P Powchik, J P Blass, K L Davis. Biol Psychiatry 1988
10
Can 4-aminopyridine be used to reverse anaesthesia and muscle relaxation?
C Carlsson, I Rosén, E Nilsson. Acta Anaesthesiol Scand 1983
C Carlsson, I Rosén, E Nilsson. Acta Anaesthesiol Scand 1983
54
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.